There was a higher tendency to use angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs), beta-blockers and aspirin in OS patients than in COPD patients (all p < 0.001); however, compared with OSAS patients, this tendency was significantly reduced. The gene discussed is ACE; the disease is chronic obstructive pulmonary disease.